Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.
Barrette AM, Ronk H, Joshi T, Mussa Z, Mehrotra M, Bouras A, Nudelman G, Jesu Raj JG, Bozec D, Lam W, Houldsworth J, Yong R, Zaslavsky E, Hadjipanayis CG, Birtwistle MR, Tsankova NM.
Barrette AM, et al. Among authors: jesu raj jg.
Neuro Oncol. 2022 May 4;24(5):694-707. doi: 10.1093/neuonc/noab244.
Neuro Oncol. 2022.
PMID: 34657158
Free PMC article.